January 9, 2018 (Investorideas.com Newswire) The CSE reports the common shares of Sunniva Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at thecse.com on the trading date.
Sunniva Inc., through its subsidiaries, is a vertically integrated medical cannabis company operating in the two largest markets – California and Canada. Sunniva is committed to becoming one of the lowest cost producers delivering safe, high-quality products and services at scale free of pesticides and/or other contaminants.
Les actions ordinaires de Sunniva Inc. ont été approuvées pour inscription à la cote du CSE.
Les documents d’inscription et de divulgation seront disponibles sur thecse.com à la date de négociation.
Sunniva Inc., par le biais de ses filiales, est une société de cannabis médical intégrée verticalement qui opère dans les deux plus grands marchés – la Californie et le Canada. Sunniva s’engage à devenir l’un des producteurs les moins chers offrant des produits et services sûrs et de haute qualité à l’échelle sans pesticides et / ou autres contaminants.
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com
Si vous avez des questions ou si vous avez besoin d’informations supplémentaires, veuillez contacter
le service des inscriptions au 416 367-7340 ou par courriel à l’adresse: Listings@thecse.com
About the CSE
The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets. http://thecse.com/
Investorideas.com is a listed service provider on the Canadian Securities Exchange http://thecse.com/en/services/services-for-listed-companies/investorideascom
This news is published on the Investorideas.com Newswire – a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 – all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Source: New feed